FAYETTEVILLE, Ark. – Medical technology company SFC Fluidics has announced a new Industry Discovery and Development Partnership supported by JDRF to develop an insulin patch pump with open-protocol communication capabilities. JDRF launched its Open-Protocol Automated Insulin Delivery (AID) Systems Initiative in 2017 with the goal of working with key stakeholders to understand the regulatory and liability implications of an “open-protocol” AID ecosystem and to accelerate the delivery of such components to market. “We are excited to support SFC in its open-protocol pump development as a key step toward the realization of our goal of an open-protocol AID ecosystem,” said Daniel Finan, JDRF research director, in a statement. “We are hopeful that solutions such as this will greatly expand choice in the marketplace, increase adoption of advanced, life-improving technologies among people with T1D, and accelerate the cadence of innovation in these treatment options.” The development and delivery to market of a fully interoperable, open-protocol insulin pump is the goal of this JDRF-SFC partnership. The two-year funding commitment from JDRF enables SFC to accelerate the development and regulatory submission of an open-protocol patch pump system that enables seamless, secure connectivity with other devices like interoperable continuous glucose monitors and third-party AID algorithms. SFC will develop a fully functional patch pump that will operate on its own platform, as well as publish its communication protocol, so that approved devices can communicate with the patch pump.
You are here: / / SFC Fluidics partners with JDRF on insulin patch pump